Medscape: Analysis boosts Fluvoxamine for COVID, but what's the evidence?
UC expert says research may be useful, but more trials are needed
A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 treatment arsenal. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Creative + Brand
"This research might be valuable, but the jury remains out until several other adequately powered and designed trials are completed," said Fichtenbaum, who's familiar with the findings. "I'm not sure how useful this is given we have several antiviral agents available. Why would we choose this over Paxlovid, remdesivir, or molnupiravir?"
According to Fichtenbaum, researchers began focusing on fluvoxamine after case reports about patients improving while on the medication. This led to further interest, he said, boosted by the drug's known ability to dampen the immune system.
Lead photo/Science News
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Ticks that survive pesticides can withstand colder winters
July 17, 2026
Ticks that survive less-than-lethal doses of pesticide are able to withstand dangerous cold, which could help them expand their range farther north, according to researchers at the University of Cincinnati and the U.S. Department of Agriculture.
Why does it feel like so many Cincinnati restaurants close?
July 17, 2026
WLWT and the Cincinnati Enquirer cited UC research in reports on recent restaurant closures in the city.
UC has connection to city of legend behind 'Odyssey'
July 17, 2026
WVXU highlights a big connection between Cincinnati and director Christopher Nolan's new movie "The Odyssey." UC Classics Professor Carl Blegen led excavations at Troy in the 1930s. UC has a vast collection of photos and other records from the ambitious archaeological project.